The PSA Screening for HIM Act, which stands for Prostate-Specific Antigen Screening for High-risk Insured Men Act, aims to require insurance coverage for prostate-specific antigen (PSA) screening for high-risk men. This bill seeks to ensure that men at a higher risk of developing prostate cancer have access to this important screening tool by mandating insurance coverage. The main provision is the requirement for insurers to cover PSA screenings for men who are considered high-risk based on certain criteria. This bill could lead to earlier detection and treatment of prostate cancer in high-risk individuals, potentially improving health outcomes and reducing mortality rates associated with this disease.
2023-03-28: Introduced in House
2023-03-28: Referred to the House Committee on Energy and Commerce.
2023-04-07: Referred to the Subcommittee on Health.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..